Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
Cancer Chemotherapy and Pharmacology|April 23, 2016
A phase 0 clinical trial of novel candidate extended-release formulations of capecitabineBart A W Jacobs, Jelte Meulenaar, Hilde Rosing, et al.
Bioanalysis|December 15, 2015
Development and clinical validation of an LC-MS/MS method for the quantification of pazopanib in DBSRemy B Verheijen, Sander Bins, Bas Thijssen, et al.
International Journal of Cancer|September 21, 2017
Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiencyLinda M Henricks, Ester J M Siemerink, Hilde Rosing, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 2, 2011
Mass balance study of [¹⁴C]eribulin in patients with advanced solid tumorsAnne-Charlotte Dubbelman, Hilde Rosing, Robert S Jansen, et al.
Pharmaceutical Research|May 9, 2020
Phase I pharmacological study of continuous chronomodulated capecitabine treatmentJeroen Roosendaal, Bart A W Jacobs, Dick Pluim, et al.
Plos One|November 14, 2024
Platinum retention in plasma, urine, and normal colonic mucosa in cisplatin-treated testicular cancer survivorsEmilie C H Breekveldt, Berbel L M Ykema, Alwin D R Huitema, et al.
Pharmacology Research & Perspectives|July 30, 2020
No relation between docetaxel administration route and high-grade diarrhea incidenceJeroen J M A Hendrikx, Frederik E Stuurman, Ji-Ying Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Bayesian pharmacokinetically guided dosing of paclitaxel in patients with non-small cell lung cancerMilly E de Jonge, H J G Desirée van den Bongard, Alwin D R Huitema, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic studyStephan A Veltkamp, Robert S Jansen, Sophie Callies, et al.
Molecular Pharmaceutics|August 29, 2015
P-glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain Disposition and Oral Availability of the Novel Taxane Cabazitaxel (Jevtana) in MiceSeng Chuan Tang, Anita Kort, Ka Lei Cheung, et al.
Pageof 23